Intellia Therapeutics To Present At 35th Annual Cowen and Company Healthcare Conference
Intellia Therapeutics, founded to develop therapeutic products using CRISPR/Cas9 technology for gene editing and repair, announced today that Nessan Bermingham, PhD, Intellia's Chief Executive Officer, will be presenting at the 35th Annual Cowen and Company Health Care Conference.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.